Understanding the efficacy variables of an HIV vaccine trial.
Global Health Program, Bill and Melinda Gates Foundation, Seattle, WA 98102, USA. Jose.Esparza@Gatesfoundation.org
José
J
Esparza
D016915:AIDS Vaccines / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D008297:Male; D012309:Risk-Taking
D016915:AIDS Vaccines; C112734:AIDSVAX; C574872:AIDSVAX B-E